These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 14756822)

  • 1. Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex.
    Devoto P; Flore G; Pira L; Longu G; Gessa GL
    J Neurochem; 2004 Feb; 88(4):1003-9. PubMed ID: 14756822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex.
    Devoto P; Flore G; Longu G; Pira L; Gessa GL
    Synapse; 2003 Dec; 50(3):200-5. PubMed ID: 14515337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noradrenergic terminals are the primary source of α
    Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
    Devoto P; Flore G; Pani L; Gessa GL
    Mol Psychiatry; 2001 Nov; 6(6):657-64. PubMed ID: 11673793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Destruction of noradrenergic terminals increases dopamine concentration and reduces dopamine metabolism in the medial prefrontal cortex.
    Gálosi R; Petykó Z; Kállai V; Tóth A; Ollmann T; Péczely L; Kovács A; Berta B; Lénárd L
    Behav Brain Res; 2018 May; 344():57-64. PubMed ID: 29454007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic.
    Devoto P; Flore G; Vacca G; Pira L; Arca A; Casu MA; Pani L; Gessa GL
    Psychopharmacology (Berl); 2003 Apr; 167(1):79-84. PubMed ID: 12632247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
    Devoto P; Flore G; Pira L; Longu G; Gessa GL
    Eur J Pharmacol; 2004 Mar; 487(1-3):105-11. PubMed ID: 15033381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex.
    Pan WH; Yang SY; Lin SK
    Synapse; 2004 Jul; 53(1):44-52. PubMed ID: 15150740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex.
    Devoto P; Sagheddu C; Santoni M; Flore G; Saba P; Pistis M; Gessa GL
    Front Pharmacol; 2020; 11():588160. PubMed ID: 33071798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex.
    Devoto P; Flore G; Saba P; Castelli MP; Piras AP; Luesu W; Viaggi MC; Ennas MG; Gessa GL
    J Neurosci Res; 2008 May; 86(7):1647-58. PubMed ID: 18189323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
    Devoto P; Flore G; Pira L; Diana M; Gessa GL
    Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex.
    Devoto P; Flore G; Saba P; Frau R; Gessa GL
    Brain Behav; 2015 Oct; 5(10):e00393. PubMed ID: 26516613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus.
    Devoto P; Flore G; Saba P; Fà M; Gessa GL
    BMC Neurosci; 2005 May; 6():31. PubMed ID: 15865626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of extracellular dopamine by the norepinephrine transporter.
    Yamamoto BK; Novotney S
    J Neurochem; 1998 Jul; 71(1):274-80. PubMed ID: 9648875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine.
    Valentini V; Frau R; Di Chiara G
    J Neurochem; 2004 Feb; 88(4):917-27. PubMed ID: 14756813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex.
    Gresch PJ; Sved AF; Zigmond MJ; Finlay JM
    J Neurochem; 1995 Jul; 65(1):111-6. PubMed ID: 7790854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potent α
    Frau R; Devoto P; Aroni S; Saba P; Sagheddu C; Siddi C; Santoni M; Carli M; Gessa GL
    Neuropharmacology; 2022 Oct; 217():109192. PubMed ID: 35850212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential alpha-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade.
    Valentini V; Cacciapaglia F; Frau R; Di Chiara G
    J Neurochem; 2006 Jul; 98(1):113-21. PubMed ID: 16805801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
    Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M
    Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons?
    Devoto P; Flore G
    Curr Neuropharmacol; 2006 Apr; 4(2):115-25. PubMed ID: 18615131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.